Sign in
4

Changes in Ownership

SAB Biotherapeutics, Inc. Filed Acc 0001209191-22-060440

Director acquired 41,493 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Link David Charles Director 2022-12-07 Grant or award +41,493 $1.21 $49,999 57,313 D
Derivatives
Link David Charles Director 2022-12-07 Grant or award · Warrant (Common Stock) +41,493 41,493 D
Loading xslF345X03/doc4.xml…